| Jun 2008 | 2007 | 2006 | |||||
|---|---|---|---|---|---|---|---|
| Total Revenues ($Mil): | 0.05 | 0.30 | 0.26 | ||||
| Depreciation & Amort ($Mil): | 0.03 | 0.03 | 0.05 | ||||
| Operating Income ($Mil): | -8.77 | -6.33 | -3.10 | ||||
| Net Income ($Mil): | -8.66 | -6.17 | -3.14 | ||||
| Earnings Per Share ($): | -0.30 | -0.24 | N/C | ||||
| Dividends ($): | 0.00 | 0.00 | 0.00 |
| Jun 2008 | 2007 | 2006 | |||||
|---|---|---|---|---|---|---|---|
| Current Assets ($Mil): | 7.04 | 7.53 | 1.84 | ||||
| Current Liabilities ($Mil): | 0.93 | 1.01 | 0.36 | ||||
| Long Term Debt ($Mil): | 0.00 | 0.00 | 0.02 | ||||
| Shares Outstanding (000): | 32080 | 30040 | 0 | 0 | 0 | 0 | 0 |
| Common Equity ($Mil): | 6.46 | 6.80 | 1.55 |
| Jun 2008 | 2007 | 2006 | |||||
|---|---|---|---|---|---|---|---|
| Profit Margin (%): | -17320.00 | -2056.67 | -1207.69 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Equity (%): | -145.60 | -90.74 | -202.58 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Assets (%): | -131 | -78.90 | -162.69 | 0.00 | 0.00 | 0.00 | 0.00 |
| P/E Ratio: | 0 | -12.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price/Book: | 8 | 13.21 | 0.00 | NaN | NaN | NaN | NaN |
| Debt Equity: | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage: | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book Value ($): | 0.20 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price/Sales: | 234.31 | 1032.98 | 0.00 | NaN | NaN | NaN | NaN |
| Dividend Payout (%): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |

| AMGEN INC. | +9.10 | 56.09 | |
| GILEAD SCIENCES | -1.80 | 45.91 | |
| CELGENE CORPORA | -8.00 | 58.56 | |
| BIOGEN IDEC INC | -31.90 | 43.13 | |
| STEMCELLS INC. | -56.40 | 1.23 |
